Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study

BACKGROUND: Around 30% of patients with schizophrenia are considered treatment resistant (TRS). Only around 40% of TRS patients respond to clozapine. Long acting injectable antipsychotics could be a useful augmentation strategy for nonresponders. METHODS: We conducted a multicenter, observational, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Bioque, Miquel, Parellada, Eduard, García-Rizo, Clemente, Amoretti, Sílvia, Fortea, Adriana, Oriolo, Giovanni, Palau, Pol, Boix-Quintana, Ester, Safont, Gemma, Bernardo, Miquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443780/
https://www.ncbi.nlm.nih.gov/pubmed/32669145
http://dx.doi.org/10.1192/j.eurpsy.2020.72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443780/
https://www.ncbi.nlm.nih.gov/pubmed/32669145
http://dx.doi.org/10.1192/j.eurpsy.2020.72

Ejemplares similares